Please login to the form below

Not currently logged in

Chiesi's Holoclar wins UK Prix Galien orphan drug award

Prix Galien Chiesi Holoclar

Novartis and Astellas also scoop prizes at the prestigious ceremony

Virgo Health launches healthcare innovation hub

The Egg service specialises in creating holistic solutions for patients and HCPs

Consilium Strategic Communications wins Vectura account

Will advise on financial and corporate PR following SkyePharma merger

Novartis seeks first-line use for lung cancer drug Zykadia

Novartis HQLooks to go head-to-head with Pfizer/Merck KGaA’s Xalkori and Roche’s Alecensa

The Prostate Project kicks of 2016 OctoBeardFest campaign

Aims to raise awareness and funds for prostate cancer research

Lundbeck trial failure dashes hopes in Alzheimer's once again

Lundbeck HQPhase III trial fails to substantially improve cognition despite promising phase II data

Gilead's ulcerative colitis antibody flunks trial

Gilead SciencesHalts trial early as preliminary data shows no evidence of efficacy

AZ withdraws EU filing for ovarian cancer drug cediranib

AstraZeneca AZ headquarters London UKMaintains cediranib’s value as a combination therapy despite EMA information request

Surviving Brexit

How UK biopharma must adapt to a changing landscape

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

Market access improvements in Turkey
Showcasing our multichannel capabilities in Berlin
Join Anthill for conferences in October to understand how to bring value to HCPs through multichannel communications...
What is MaxDiff?
MaxDiff - (aka maximum difference scaling) can help market researchers pare down a wealth of information into precise and actionable insights. Sarah Mackinnon, Research Manager at Creative Medical Research, looks...